FDA Approves Wegovy Oral Pill for Weight Loss | New GLP-1 Treatment
FDA Approves Wegovy Pill: A Breakthrough in Oral GLP-1 Weight Loss Medication Summary : FDA Approval: The FDA has approved Wegovy’s first-ever oral version, a weight-loss pill from Novo Nordisk containing semaglutide, the active ingredient in both Wegovy and Ozempic. Pill vs. Injection: This new pill version offers a daily oral alternative to
FDA Approves Wegovy Oral Pill for Weight Loss | New GLP-1 Treatment Read More »